Commercial: Is the 340B Drug Pricing Program the Next ‘Too Big to Fail’?
WASHINGTON, DC, October 23, 2025 /24-7PressRelease/ — ADAP Advocacy today, as part of its 340B Project, aired its latest commercial calling for reforms to the 340B Drug Pricing Program. The commercial calls out excessive executive compensation for 340B-eligible hospital CEOs, asking a critical question: “Is the 340B Drug Pricing Program the Next ‘Too Big to Fail’?“
Brandon M. Macsata, CEO of ADAP Advocacy, summarized: “Hospital CEOs are being compensated 200-300% more than the nurses providing the direct patient care, and sometimes even above, largely financed by a program designed to help low-income patients access healthcare services. Anyone who suggests the 340B program isn’t benefiting providers and their executives more than patients is being intellectually dishonest. Patients learn about this level of pay and compare it to the medical debt that they’re carrying, and it literally makes them sick.”
The new commercial is part of the ‘340B Too Big To Fail’ national advocacy campaign, which will run through the end of the year, highlighting hospitals’ declining charity, rising healthcare executive compensation, and exploding patient medical debt, among some other issues. ADAP Advocacy’s interactive map has elevated these trends.
The commercial is available online at https://youtu.be/Q8zaGIZqDp4.
To learn more about ADAP Advocacy, 340B Drug Pricing Program, excessive hospital CEO pay, or the new 340B commercial, please email info@adapadvocacy.org.
About ADAP Advocacy: ADAP Advocacy’s mission is to promote and enhance the AIDS Drug Assistance Programs (ADAPs) and improve access to care for persons living with HIV/AIDS. ADAP Advocacy works with advocates, community, health care, government, patients, pharmaceutical companies, and other stakeholders to raise awareness, offer patient educational programs, and foster greater community collaboration.
—
For the original version of this press release, please visit 24-7PressRelease.com here
Legal Disclaimer:
The content on this page is syndicated from independent third-party providers. Kyrion Media makes no warranties or representations regarding the accuracy, completeness, legality, or reliability of the information, including text, images, videos, or licenses. If you are affiliated with this content or have any complaints, copyright concerns, or requests for removal, please contact us at retract@kyrionmedia.com with the specific URL of the content in question. We will review and address valid requests promptly.
